This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Apr;19(4):413-417.

doi: 10.1080/14787210.2021.1828062. Epub 2020 Oct 7.

Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course

Mudit Agarwal¹, Piyush Ranjan², Ankit Mittal², Upendra Baitha²

Affiliations

Affiliations

¹ All India Institute of Medical Sciences, New Delhi, India.
² Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.

PMID: 32981388
DOI: 10.1080/14787210.2021.1828062

Editorial

Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course

Mudit Agarwal et al. Expert Rev Anti Infect Ther. 2021 Apr.

. 2021 Apr;19(4):413-417.

doi: 10.1080/14787210.2021.1828062. Epub 2020 Oct 7.

Authors

Mudit Agarwal¹, Piyush Ranjan², Ankit Mittal², Upendra Baitha²

Affiliations

¹ All India Institute of Medical Sciences, New Delhi, India.
² Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.

PMID: 32981388
DOI: 10.1080/14787210.2021.1828062

No abstract available

Keywords: COVID-19; Hydroxychloroquine; SARS-CoV-2; pre-exposure prophylaxis.

PubMed Disclaimer

Similar articles

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
Revollo B, Tebe C, Peñafiel J, Blanco I, Perez-Alvarez N, Lopez R, Rodriguez L, Ferrer J, Ricart P, Moret E, Tural C, Carreres A, Matllo J, Videla S, Clotet B, Llibre JM. Revollo B, et al. J Antimicrob Chemother. 2021 Feb 11;76(3):827-829. doi: 10.1093/jac/dkaa477. J Antimicrob Chemother. 2021. PMID: 33219675 Free PMC article. No abstract available.
Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19.
Hennekens CH, Rane M, Solano J, Alter S, Johnson H, Krishnaswamy S, Shih R, Maki D, DeMets DL. Hennekens CH, et al. Am J Med. 2022 Jan;135(1):7-9. doi: 10.1016/j.amjmed.2021.07.035. Epub 2021 Aug 23. Am J Med. 2022. PMID: 34437834 Free PMC article. No abstract available.
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
Mehta S, Bhandari S, Mehta S. Mehta S, et al. J Glob Antimicrob Resist. 2020 Sep;22:864-865. doi: 10.1016/j.jgar.2020.07.022. Epub 2020 Aug 7. J Glob Antimicrob Resist. 2020. PMID: 32777441 Free PMC article.
The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
Lewis K, Chaudhuri D, Alshamsi F, Carayannopoulos L, Dearness K, Chagla Z, Alhazzani W; GUIDE Group. Lewis K, et al. PLoS One. 2021 Jan 6;16(1):e0244778. doi: 10.1371/journal.pone.0244778. eCollection 2021. PLoS One. 2021. PMID: 33406138 Free PMC article.
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB, Dash AP. Nina PB, et al. Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20. Indian J Public Health. 2020. PMID: 32496241 Review.

See all similar articles

Cited by

Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review.
Agarwal M, Ranjan P, Baitha U, Mittal A. Agarwal M, et al. Front Pharmacol. 2020 Dec 17;11:593099. doi: 10.3389/fphar.2020.593099. eCollection 2020. Front Pharmacol. 2020. PMID: 33390974 Free PMC article. Review.
Assessment of Preventive Practices Followed by General Public During COVID-19 Pandemic - A Cross-Sectional Survey From India.
Chakrawarty A, Ranjan P, Thrinath A, Aggarwal E, Isaac JA, Berry P, Baitha U, Upadhyay AD, Chowdhury S, Kumar A. Chakrawarty A, et al. Cureus. 2020 Oct 31;12(10):e11274. doi: 10.7759/cureus.11274. Cureus. 2020. PMID: 33274149 Free PMC article.
Socio-behavioural impact of COVID-19 on general population: A cross-sectional survey of one thousand seventy-nine participants across India between the first and the second wave of pandemic.
Klanidhi KB, Ranjan P, Kaur T, Khan M, Ghosh T, Upadhyay AD, Chopra S, Sarkar S, Kaloiya GS, Barre VP, Singh A, Prakash B. Klanidhi KB, et al. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102144. doi: 10.1016/j.dsx.2021.05.017. Epub 2021 May 27. Diabetes Metab Syndr. 2021. PMID: 34186356 Free PMC article.
Association Between Self-Reported Adherence to Preventive Practices and Probability of Turning COVID-19 Positive: A Cross-Sectional Analytical Study.
Ranjan P, Bhattacharya A, Chakrawarty A, Das R, Kumar A, Pandey S, Chowdhury S, Mittal A, Baitha U, Wig N. Ranjan P, et al. Cureus. 2020 Dec 1;12(12):e11815. doi: 10.7759/cureus.11815. Cureus. 2020. PMID: 33409060 Free PMC article.
Can use of hydroxychloroquine and azithromycin as a treatment of COVID-19 affect aquatic wildlife? A study conducted with neotropical tadpole.
da Luz TM, Araújo APDC, Estrela FN, Braz HLB, Jorge RJB, Charlie-Silva I, Malafaia G. da Luz TM, et al. Sci Total Environ. 2021 Aug 1;780:146553. doi: 10.1016/j.scitotenv.2021.146553. Epub 2021 Mar 18. Sci Total Environ. 2021. Retraction in: Sci Total Environ. 2024 Dec 20;957:177813. doi: 10.1016/j.scitotenv.2024.177813. PMID: 33774288 Free PMC article. Retracted.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal